Replies to post #76957 on Titan Medical Inc (TMDIF)

[longtermgems]

Trxc was valued at $50M four months before it received Senhance fda approval. Didn’t touch $1B valuation until after US approval and sales started rolling in. Tmdi should be valued at no more than $100M until they receive fda approval

[SavageWildlings]

This is how I know you’re wrong. I’ve kept every share in Titan before and after reverse split. I haven't sold a single share because there’s no urgency on my end and I would for sure take a loss. I’m young and patient with this company and can afford to be that way for half a century more. However, you come on this board and start to spew crap with little evidence to support your claims. You generate the “fear” of not buying which leads to others jumping on board. Pumping up a stock that has no source of profit / revenue is reckless, disrespectful and dishonest. Non of your theories have come to fruition. If anything, you’re the prime behavior of a real shorter.

To everyone else, I think they have a good product but now is not the time to dive in... we are still in shallow waters. That opportunity will come as they advance passed CE / FDA approval and start selling their units.

GLTA